Reuters logo
BRIEF-PureTech affiliate Gelesis reports weight loss in study
September 25, 2017 / 6:19 AM / 3 months ago

BRIEF-PureTech affiliate Gelesis reports weight loss in study

Sept 25 (Reuters) - Puretech Health Plc

* ‍gelesis reports significant weight loss with excellent safety profile in pivotal study with gelesis100​

* ‍study achieved and exceeded one of two co-primary endpoints with 58% of adults in gelesis100 treatment arm achieving 5% or more weight loss​

* ‍study did not meet other co-primary endpoint of 3% mean difference from placebo​ Source text for Eikon: Further company coverage: (Reporting By London Bureau)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below